Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $97,434 - $123,871
-708 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $1.76 Million - $2.18 Million
-13,342 Reduced 94.96%
708 $115,000
Q4 2021

Feb 03, 2022

BUY
$107.43 - $135.93 $194,233 - $245,761
1,808 Added 14.77%
14,050 $1.9 Million
Q3 2021

Oct 27, 2021

BUY
$106.4 - $120.78 $181,731 - $206,292
1,708 Added 16.21%
12,242 $1.32 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $232,619 - $259,151
2,211 Added 26.56%
10,534 $1.19 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $295,033 - $324,796
2,884 Added 53.02%
8,323 $901,000
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $144,157 - $194,627
1,791 Added 49.1%
5,439 $582,000
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $3.23 Million - $3.79 Million
-37,632 Reduced 91.16%
3,648 $320,000
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $45,660 - $54,897
-725 Reduced 1.73%
41,280 $3 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $2.76 Million - $3.53 Million
42,005 New
42,005 $3.06 Million
Q1 2019

May 03, 2019

SELL
$77.14 - $90.79 $339,416 - $399,476
-4,400 Closed
0 $0
Q4 2018

Feb 11, 2019

BUY
$77.85 - $96.01 $342,540 - $422,444
4,400 New
4,400 $406,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $335B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Greenwood Capital Associates LLC Portfolio

Follow Greenwood Capital Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.